Bone Metastatic Diagnostics Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Bone Metastatic Diagnostics Market to 2027 - Global Analysis and Forecasts By Type (Osteolytic Bone Metastasis, Osteoblastic Bone Metastasis, Mixed Bone Metastasis and Others), Diagnosis (Biopsy, Blood Test, Imaging and Others), End User (Hospitals, Ambulatory Surgical Centers and Others) and Geography

Report Code: TIPMD00002572 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
Bone metastasis is spread of the cancer cells from the original site to a bone, all the types of cancer generally spreads to a bone. However, few types of the cancer which includes breast and prostate cancer are likely to spread to bone. Generally bone metastasis is sign that tells about the occurrence of the cancer in a person. The symptoms of bone metastasis include urinary incontinence, bone pain, broken bones, weakness in limbs, and high levels of calcium in blood among the others.

The bone metastasis diagnostics market is likely to anticipate grow with a significant rate in the forecast years, owing to driving factors such as, rise in the prevalence of the cancers, adoption of unhealthier lifestyle, rise in the consumption of tobacco and alcohols among others. In addition, the advancement in the technology has led to the innovation of the medical diagnostic devices, and also technological advancement has created a wide pool of opportunities to the market players to enter in the emerging nations.

The "Global Bone Metastasis Diagnostics Market Analysis To 2027" is a specialized and in-depth study of the medical device industry with a focus on the bone metastasis diagnostics market trend. The report aims to provide an overview of global bone metastasis diagnostics market with detailed market segmentation by type, diagnosis end user and geography. The global bone metastasis diagnostics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the bone metastasis diagnostics market.

The global bone metastasis diagnostics market is segmented on the basis of type, diagnosis and end user. The type segment includes osteolytic bone metastasis, osteoblastic bone metastasis, mixed bone metastasis and others. On the basis of the diagnosis the market is categorized into biopsy, blood test, imaging and others. Based on the end user the market is segmented as hospitals, ambulatory surgical centers and others.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global bone metastasis diagnostics market based on type, diagnosis, end user and geography. It also provides market size and forecast till 2027 for overall bone metastasis diagnostics market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

North America is expected to contribute to the largest share in the bone metastasis diagnostics market in the coming years, owing to factors such as, higher technological advancement, large number of players operating in the region and more, Europe is expected to hold the second largest market in the global scenarios. Whereas, Asia Pacific is anticipated as the fastest growing for the bone metastasis diagnostics market owing to the rise in the prevalence of the cancer and consumption of the alcohol and tobacco.

The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The report also includes the profiles of key bone metastasis diagnostics market manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Medtronic, General Electric Company, Koninklijke Philips N.V., Siemens Healthcare GmbH, Carestream Health., FUJIFILM Corporation, Canon Medical Systems, USA, Hitachi, Ltd., Brainlab AG and FMI Medical Systems, Inc.
Table of Contents

1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

2. KEY TAKEAWAYS

3. BONE METASTATIC DIAGNOSTICS MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Bone Metastatic Diagnostics Market - By Type
3.2.2. Bone Metastatic Diagnostics Market - By Diagnosis
3.2.3. Bone Metastatic Diagnostics Market - By End User
3.2.4. Bone Metastatic Diagnostics Market - By Region
3.2.4.1. By Country
3.3. PEST ANALYSIS
3.3.1. North America - PEST Analysis
3.3.2. Europe - PEST Analysis
3.3.3. Asia Pacific - PEST Analysis
3.3.4. Middle East and Africa - PEST Analysis
3.3.5. South and Central America- PEST Analysis

4. BONE METASTATIC DIAGNOSTICS MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS

5. BONE METASTATIC DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - BY TYPE
5.1. OVERVIEW
5.2. TYPE MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
5.3. OSTEOLYTIC BONE METASTASIS MARKET
5.3.1. Overview
5.3.2. Osteolytic Bone Metastasis Market Revenue Forecasts and Analysis (US$ Mn)
5.4. OSTEOBLASTIC BONE METASTASIS MARKET
5.4.1. Overview
5.4.2. Osteoblastic Bone Metastasis Market Revenue Forecasts and Analysis (US$ Mn)
5.5. MIXED BONE METASTASIS MARKET
5.5.1. Overview
5.5.2. Mixed Bone Metastasis Market Revenue Forecasts and Analysis (US$ Mn)
5.6. OTHERS MARKET
5.6.1. Overview
5.6.2. Others Market Revenue Forecasts and Analysis (US$ Mn)

6. BONE METASTATIC DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - BY DIAGNOSIS
6.1. OVERVIEW
6.2. DIAGNOSIS MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
6.3. BIOPSY MARKET
6.3.1. Overview
6.3.2. Biopsy Market Revenue Forecasts and Analysis (US$ Mn)
6.4. BLOOD TEST MARKET
6.4.1. Overview
6.4.2. Blood Test Market Revenue Forecasts and Analysis (US$ Mn)
6.5. IMAGING MARKET
6.5.1. Overview
6.5.2. Imaging Market Revenue Forecasts and Analysis (US$ Mn)
6.5.2.1. X-Ray Market
6.5.2.1.1. Overview
6.5.2.1.2. X-Ray Market Revenue Forecasts and Analysis (US$ Mn)
6.5.2.2. Bone Scintigraphy Market
6.5.2.2.1. Overview
6.5.2.2.2. Bone Scintigraphy Market Revenue Forecasts and Analysis (US$ Mn)
6.5.2.3. Computerized Tomography Market
6.5.2.3.1. Overview
6.5.2.3.2. Computerized Tomography Market Revenue Forecasts and Analysis (US$ Mn)
6.5.2.4. Magnetic Resonance Imaging Market
6.5.2.4.1. Overview
6.5.2.4.2. Magnetic Resonance Imaging Market Revenue Forecasts and Analysis (US$ Mn)
6.5.2.5. Others Market
6.5.2.5.1. Overview
6.5.2.5.2. Others Market Revenue Forecasts and Analysis (US$ Mn)
6.6. OTHERS MARKET
6.6.1. Overview
6.6.2. Others Market Revenue Forecasts and Analysis (US$ Mn)

7. BONE METASTATIC DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - BY END USER
7.1. OVERVIEW
7.2. END USER MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. HOSPITALS MARKET
7.3.1. Overview
7.3.2. Hospitals Market Revenue Forecasts and Analysis (US$ Mn)
7.4. HOMECARE SETTINGS MARKET
7.4.1. Overview
7.4.2. Homecare Settings Market Revenue Forecasts and Analysis (US$ Mn)
7.5. OTHERS MARKET
7.5.1. Overview
7.5.2. Others Market Revenue Forecasts and Analysis (US$ Mn)

8. NORTH AMERICA BONE METASTATIC DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
8.1. NORTH AMERICA BONE METASTATIC DIAGNOSTICS MARKET OVERVIEW
8.2. NORTH AMERICA BONE METASTATIC DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
8.3. NORTH AMERICA BONE METASTATIC DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
8.4. NORTH AMERICA BONE METASTATIC DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TREATMENT (US$ MN)
8.4.1. North America Imaging Market Revenue Forecasts and Analysis - By Type (US$ Mn)
8.5. NORTH AMERICA BONE METASTATIC DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
8.6. NORTH AMERICA BONE METASTATIC DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
8.7. US MARKET OVERVIEW
8.7.1. US Bone Metastatic Diagnostics Market Revenue Forecasts and Analysis - By Type (US$ Mn)
8.7.2. US Bone Metastatic Diagnostics Market Revenue Forecasts and Analysis - By Diagnosis (US$ Mn)
8.7.2.1. US Imaging Market Revenue Forecasts and Analysis - By Type (US$ Mn)
8.7.3. US Bone Metastatic Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
8.8. CANADA MARKET OVERVIEW
8.8.1. Canada Bone Metastatic Diagnostics Market Revenue Forecasts and Analysis - By Type (US$ Mn)
8.8.2. Canada Bone Metastatic Diagnostics Market Revenue Forecasts and Analysis - By Diagnosis (US$ Mn)
8.8.2.1. Canada Imaging Market Revenue Forecasts and Analysis - By Type (US$ Mn)
8.8.3. Canada Bone Metastatic Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
8.9. MEXICO MARKET OVERVIEW
8.9.1. Mexico Bone Metastatic Diagnostics Market Revenue Forecasts and Analysis - By Type (US$ Mn)
8.9.2. Mexico Bone Metastatic Diagnostics Market Revenue Forecasts and Analysis - By Diagnosis (US$ Mn)
8.9.2.1. Mexico Imaging Market Revenue Forecasts and Analysis - By Type (US$ Mn)
8.9.3. Mexico Bone Metastatic Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)

9. EUROPE BONE METASTATIC DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
9.1. EUROPE BONE METASTATIC DIAGNOSTICS MARKET OVERVIEW
9.2. EUROPE BONE METASTATIC DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
9.3. EUROPE BONE METASTATIC DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
9.4. EUROPE BONE METASTATIC DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY DIAGNOSIS (US$ MN)
9.4.1. Europe Imaging Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.5. EUROPE BONE METASTATIC DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
9.6. EUROPE BONE METASTATIC DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
9.7. UK MARKET OVERVIEW
9.7.1. UK Bone Metastatic Diagnostics Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.7.2. UK Bone Metastatic Diagnostics Market Revenue Forecasts and Analysis - By Diagnosis (US$ Mn)
9.7.2.1. UK Imaging Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.7.3. UK Bone Metastatic Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.8. GERMANY MARKET OVERVIEW
9.8.1. Germany Bone Metastatic Diagnostics Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.8.2. Germany Bone Metastatic Diagnostics Market Revenue Forecasts and Analysis - By Diagnosis (US$ Mn)
9.8.2.1. Germany Imaging Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.8.3. Germany Bone Metastatic Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.9. FRANCE MARKET OVERVIEW
9.9.1. France Bone Metastatic Diagnostics Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.9.2. France Bone Metastatic Diagnostics Market Revenue Forecasts and Analysis - By Diagnosis (US$ Mn)
9.9.2.1. France Imaging Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.9.3. France Bone Metastatic Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10. ASIA PACIFIC BONE METASTATIC DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
10.1. ASIA PACIFIC BONE METASTATIC DIAGNOSTICS MARKET OVERVIEW
10.2. ASIA PACIFIC BONE METASTATIC DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. ASIA PACIFIC BONE METASTATIC DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
10.4. ASIA PACIFIC BONE METASTATIC DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY DIAGNOSIS (US$ MN)
10.4.1. Asia Pacific Imaging Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.5. ASIA PACIFIC BONE METASTATIC DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
10.6. ASIA PACIFIC BONE METASTATIC DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
10.7. CHINA MARKET OVERVIEW
10.7.1. China Bone Metastatic Diagnostics Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.7.2. China Bone Metastatic Diagnostics Market Revenue Forecasts and Analysis - By Diagnosis (US$ Mn)
10.7.2.1. China Imaging Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.7.3. China Bone Metastatic Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.8. JAPAN MARKET OVERVIEW
10.8.1. Japan Bone Metastatic Diagnostics Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.8.2. Japan Bone Metastatic Diagnostics Market Revenue Forecasts and Analysis - By Diagnosis (US$ Mn)
10.8.2.1. Japan Imaging Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.8.3. Japan Bone Metastatic Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.9. INDIA MARKET OVERVIEW
10.9.1. India Bone Metastatic Diagnostics Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.9.2. India Bone Metastatic Diagnostics Market Revenue Forecasts and Analysis - By Diagnosis (US$ Mn)
10.9.2.1. India Imaging Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.9.3. India Bone Metastatic Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)

11. MIDDLE EAST AND AFRICA BONE METASTATIC DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
11.1. MIDDLE EAST AND AFRICA BONE METASTATIC DIAGNOSTICS MARKET OVERVIEW
11.2. MIDDLE EAST AND AFRICA BONE METASTATIC DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. MIDDLE EAST AND AFRICA BONE METASTATIC DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
11.4. MIDDLE EAST AND AFRICA BONE METASTATIC DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY DIAGNOSIS (US$ MN)
11.4.1. Middle East and Africa Imaging Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.5. MIDDLE EAST AND AFRICA BONE METASTATIC DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
11.6. MIDDLE EAST AND AFRICA BONE METASTATIC DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
11.7. UAE MARKET OVERVIEW
11.7.1. UAE Bone Metastatic Diagnostics Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.7.2. UAE Bone Metastatic Diagnostics Market Revenue Forecasts and Analysis - By Diagnosis (US$ Mn)
11.7.2.1. UAE Imaging Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.7.3. UAE Bone Metastatic Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.8. SAUDI ARABIA MARKET OVERVIEW
11.8.1. Saudi Arabia Bone Metastatic Diagnostics Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.8.2. Saudi Arabia Bone Metastatic Diagnostics Market Revenue Forecasts and Analysis - By Diagnosis (US$ Mn)
11.8.2.1. Saudi Arabia Imaging Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.8.3. Saudi Arabia Bone Metastatic Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.9. SOUTH AFRICA MARKET OVERVIEW
11.9.1. South Africa Bone Metastatic Diagnostics Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.9.2. South Africa Bone Metastatic Diagnostics Market Revenue Forecasts and Analysis - By Diagnosis (US$ Mn)
11.9.2.1. South Africa Imaging Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.9.3. South Africa Bone Metastatic Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)

12. SOUTH AND CENTRAL AMERICA BONE METASTATIC DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
12.1. SOUTH AND CENTRAL AMERICA BONE METASTATIC DIAGNOSTICS MARKET OVERVIEW
12.2. SOUTH AND CENTRAL AMERICA BONE METASTATIC DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. SOUTH AND CENTRAL AMERICA BONE METASTATIC DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
12.4. SOUTH AND CENTRAL AMERICA BONE METASTATIC DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY DIAGNOSIS (US$ MN)
12.4.1. South and Central America Imaging Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.5. SOUTH AND CENTRAL AMERICA BONE METASTATIC DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
12.6. SOUTH AND CENTRAL AMERICA BONE METASTATIC DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
12.7. BRAZIL MARKET OVERVIEW
12.7.1. Brazil Bone Metastatic Diagnostics Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.7.2. Brazil Bone Metastatic Diagnostics Market Revenue Forecasts and Analysis - By Diagnosis (US$ Mn)
12.7.2.1. Brazil Imaging Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.7.3. Brazil Bone Metastatic Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.7.4.
13. INDUSTRY LANDSCAPE
13.1. 1.1.ORGANIC GROWTH STRATEGIES
13.1.1. New Product Launches
13.1.2. Marketing & Promotional Activities
13.2. 1.2.INORGANIC GROWTH STRATEGIES
13.2.1. Partnerships, Collaborations, and Joint Ventures
13.2.2. Mergers & Acquisitions

14. BONE METASTATIC DIAGNOSTICS MARKET, KEY COMPANY PROFILES
14.1. MEDTRONIC
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Financial Overview
14.1.4. Product Portfolio
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. GENERAL ELECTRIC COMPANY
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Financial Overview
14.2.4. Product Portfolio
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. KONINKLIJKE PHILIPS N.V.
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Financial Overview
14.3.4. Type/Type Portfolio
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. SIEMENS HEALTHCARE GMBH
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Financial Overview
14.4.4. Product Portfolio
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. CARESTREAM HEALTH
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Financial Overview
14.5.4. Product Portfolio
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. FUJIFILM CORPORATION
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Financial Overview
14.6.4. Product Portfolio
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. CANON MEDICAL SYSTEMS, USA
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Financial Overview
14.7.4. Product Portfolio
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. HITACHI, LTD
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Financial Overview
14.8.4. Product Portfolio
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. BRAINLAB AG
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Financial Overview
14.9.4. Product Portfolio
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. FMI MEDICAL SYSTEM, INC
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Financial Overview
14.10.4. Product Portfolio
14.10.5. SWOT Analysis
14.10.6. Key Developments

15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
15.3. RESEARCH METHODOLOGY
The List of Companies

1. Medtronic
2. GENERAL ELECTRIC COMPANY
3. Koninklijke Philips N.V.
4. Siemens Healthcare GmbH
5. Carestream Health.
6. FUJIFILM Corporation
7. Canon Medical Systems, USA
8. Hitachi, Ltd.
9. Brainlab AG
10. FMI Medical Systems, Inc.

Select License Type
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book